West nile virus immunoglobulin A (WNV IgA) detection in cerebrospinal fluid in relation to WNV IgG and IgM reactivityNIXON, Mary Lapé; PRINCE, Harry E.Journal of clinical virology. 2006, Vol 37, Num 3, pp 174-178, issn 1386-6532, 5 p.Article

ISOLATIONS OF WEST NILE VIRUS FROM MAN IN NIGERIA.OYEWALE TOMORI; ADEMOLA FAGBAMI; AKINYELE FABIYI et al.1978; TRANS. R. SOC. TROP. MED. HYG.; G.B.; DA. 1978; VOL. 72; NO 1; PP. 103-104; BIBL. 13 REF.Article

ALTERATIONS IN THE DEVELOPMENTAL PATTERNS OF ENZYMES IN CHICKEN EMBRYOS INFECTED WITH WEST NILE VIRUS.LENGLE EE; FRERMAN FE; GROSSBERG SE et al.1976; ARCH. BIOCHEM. BIOPHYS.; U.S.A.; DA. 1976; VOL. 177; NO 1; PP. 157-169; BIBL. 45 REF.Article

POLYPEPTIDES OF JAPANESE ENCEPHALITIS AND WEST NILE VIRUSESDESHMANE SL; BANERJEE K.1980; INDIAN J. MED. RES.; IND; DA. 1980-02; VOL. 71; PP. 157-163; BIBL. 16 REF.Article

Immune responses to an attenuated West Nile virus NS4B-P38G mutant strainWELTE, Thomas; GUORUI XIE; WICKER, Jason A et al.Vaccine. 2011, Vol 29, Num 29-30, pp 4853-4861, issn 0264-410X, 9 p.Article

Antiviral effect of interferon lambda against West Nile virusDONGLING MA; DONG JIANG; GUO, Ju-Tao et al.Antiviral research. 2009, Vol 83, Num 1, pp 53-60, issn 0166-3542, 8 p.Article

Evaluation of a new West Nile Virus lateral-flow rapid IgM assaySAMBOL, Anthony R; HINRICHS, Steven H.Journal of virological methods. 2009, Vol 157, Num 2, pp 223-226, issn 0166-0934, 4 p.Article

Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacyDEMENTO, Stacey L; EISENBARTH, Stephanie C; FAHMYA, Tarek M et al.Vaccine. 2009, Vol 27, Num 23, pp 3013-3021, issn 0264-410X, 9 p.Article

Error-prone replication of West Nile virus caused by ribavirinDAY, Craig W; SMEE, Donald F; JULANDER, Justin G et al.Antiviral research. 2005, Vol 67, Num 1, pp 38-45, issn 0166-3542, 8 p.Article

Assurance of neuroattenuation of a live vaccine against West Nile virus: A comprehensive study of neuropathogenesis after infection with chimeric WN/DEN4Δ30 vaccine in comparison to two parental viruses and a surrogate flavivirus reference vaccineMAXIMOV, Olga A; SPEICHER, James M; SKINNER, Jeff R et al.Vaccine. 2014, Vol 32, Num 26, pp 3187-3197, issn 0264-410X, 11 p.Article

West Nile Virus Infections in Children: A Disease Pediatricians Should Think AboutRIZZO, Caterina; ESPOSITO, Susanna; AZZARI, Chiara et al.The Pediatric infectious disease journal. 2011, Vol 30, Num 1, pp 65-66, issn 0891-3668, 2 p.Article

Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasivenessWHITEMAN, Melissa C; WICKER, Jason A; KINNEY, Richard M et al.Vaccine. 2011, Vol 29, Num 52, pp 9702-9710, issn 0264-410X, 9 p.Article

West Nile vims in the endangered Spanish imperial eagleHÖFLE, Ursula; BLANCO, Juan M; CRESPO, Elena et al.Veterinary microbiology (Amsterdam). 2008, Vol 129, Num 1-2, pp 171-178, issn 0378-1135, 8 p.Article

A recombinant envelope protein vaccine against West Nile virusLEDIZET, Michel; KAR, Kalipada; FOELLMER, Harald G et al.Vaccine. 2005, Vol 23, Num 30, pp 3915-3924, issn 0264-410X, 10 p.Article

An update on the potential of North American mosquitoes (Diptera: Culicidae) to transmit West Nile virusTURELL, Michael J; DOHM, David J; SARDELIS, Michael R et al.Journal of medical entomology. 2005, Vol 42, Num 1, pp 57-62, issn 0022-2585, 6 p.Article

Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in miceMAGNUSSON, Sofia E; KARLSSON, Karin H; DIAMOND, Michael S et al.Vaccine. 2014, Vol 32, Num 7, pp 800-808, issn 0264-410X, 9 p.Article

A West Nile virus NS4B-P38G mutant strain induces adaptive immunity via TLR7-MyD88-dependent and independent signaling pathwaysGUORUI XIE; WELTE, Thomas; JIA WANG et al.Vaccine. 2013, Vol 31, Num 38, pp 4143-4151, issn 0264-410X, 9 p.Article

Domestic goose as a model for West Nile virus vaccine efficacySA E SILVA, Mariana; ELLIS, Angela; KARACA, Kemal et al.Vaccine. 2013, Vol 31, Num 7, pp 1045-1050, issn 0264-410X, 6 p.Article

West Nile virus population genetics and evolutionPESKO, Kendra N; EBEL, Gregory D.Infection, genetics and evolution (Print). 2012, Vol 12, Num 2, pp 181-190, issn 1567-1348, 10 p.Article

Purification and concentration of non-infectious West Nile virus-like particles and infectious virions using a pseudo-affinity Cellufine Sulfate columnOHTAKI, Naohiro; TAKAHASHI, Hidehiro; KANEKO, Keiko et al.Journal of virological methods. 2011, Vol 174, Num 1-2, pp 131-135, issn 0166-0934, 5 p.Article

An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA systemORLINGER, Klaus K; HOLZER, Georg W; SCHWAIGER, Julia et al.Vaccine. 2010, Vol 28, Num 19, pp 3318-3324, issn 0264-410X, 7 p.Article

Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virusWHITEMAN, Melissa C; LI LI; WICKER, Jason A et al.Vaccine. 2010, Vol 28, Num 4, pp 1075-1083, issn 0264-410X, 9 p.Article

Immunogenicity of RepliVAX WN, a novel single-cycle West Nile virus vaccineNELSON, Michelle H; WINKELMANN, Evandro; YINGHONG MA et al.Vaccine. 2010, Vol 29, Num 2, pp 174-182, issn 0264-410X, 9 p.Article

Changing patterns of West Nile virus transmission: altered vector competence and host susceptibilityBRAULT, Aaron C.Veterinary research (Print). 2009, Vol 40, Num 2, issn 0928-4249, 2009026.1-2009026.19Article

Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation systemWIDMAN, Douglas G; ISHIKAWA, Tomohiro; FAYZULIN, Rafik et al.Vaccine. 2008, Vol 26, Num 22, pp 2762-2771, issn 0264-410X, 10 p.Article